CYTK Cytokinetics Inc

Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

$35.52  -2.63 (-6.89%)
As of 12/03/2021 15:59:57 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/29/2004
Outstanding shares:  83,882,953
Average volume:  906,479
Market cap:   $3,200,134,657
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    23282W605
ISIN:        US23282W6057
Sedol:      BBBSBJ5
Valuation   (See tab for details)
PE ratio:   -13.02
PB ratio:   11.95
PS ratio:   148.50
Return on equity:   -91.83%
Net income %:   -1,061.13%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy